Genomics Market worth 19.99 Billion USD by 2020 - PowerPoint PPT Presentation

About This Presentation

Genomics Market worth 19.99 Billion USD by 2020


The report "Genomics Market by Product (Instruments, Consumables), by Technology (Sequencing, PCR, Microarray), by Application (Diagnostics, Personalized Medicine), by Process (Library Preparation, Sequencing & Imaging), by End User - Trends & Global Forecasts to 2020" , analyzes and studies the major market drivers, restraints/challenges, and opportunities. – PowerPoint PPT presentation

Number of Views:75


Transcript and Presenter's Notes

Title: Genomics Market worth 19.99 Billion USD by 2020

MarketsandMarkets Presents
Genomics Market worth 19.99 Billion by 2020

  • New analysis from Markets and Markets "Genomics
    Market by Products - Instruments (NGS platform,
    Microarray, RT-PCR), Consumables (Gene chips,
    Reagents for DNA Extraction Purification,
    Sequencing), Services (Sequencing Microarray
    Services, and Software) - Global Forecast to
    2020" finds that the Global Genomics Market
    earned revenues of 12.05 billion in 2015 and
    estimates this market to reach over 19.99
    billion by 2020.
  • Browse 117 market data tables and 43 figures
    spread through 195 pages and in-depth TOC on
    Genomics Market by Products- Instruments (NGS
    platform, Microarray, RT-PCR), Consumables (Gene
    chips, Reagents for DNA Extraction
    Purification, Sequencing), Services (Sequencing
    Microarray Services, and Software) - Global
    Forecast to 2020"
  • http//


  • The report segments the Global Genomics market by
    products (instrument, consumables, and services),
    by technology (Nucleic acid extraction
    purification, PCR, DNA sequencing, and DNA
    microarray), by application (diagnostics,
    personalized medicine, academic research,
    agriculture animal health, and academic
    research), and by geography (North America,
    Europe, APAC, and RoW). Technological
    advancements (Nanopore sequencing, customized
    microarray, and d-PCR), increasing capital
    investment by public and private capitalists in
    genetic researches, as well as innovations in
    bioinformatics tools for advanced application in
    drug discovery and academic research are
    considered the key drivers for the global
    genomics market.
  • The future of genomics lies in the personalized
    medicine industry. Government initiatives and
    considerable investments are expected to drive
    genetic research on personalized medicines that
    utilize base pairs of the human genome sequence.

  • As of now, the application of personalized
    medicine is primarily focused on drug discovery
    for oncology, vaccine production, as well as
    infectious disease-therapeutic areas. The usage
    and application areas for genomic research in
    personalized medicine are expected to increase
    significantly in coming years.
  • Over the last decade, Tier I and Tier II
    companies were found to be dominant in the
    instruments and consumables product segments of
    the genomics market. Moreover, increasing market
    consolidation through consecutive restructuring
    activities by leading players has proved to be a
    challenge for new entrants. Market penetration
    in the genomics services sub-segment would be a
    suitable strategy for start-ups. Increasing
    dependency of small and medium scale research
    institutes on outsourced services is expected to
    drive the market significantly, concludes Antan.
    Partnering with Tier I and Tier II manufacturers
    reduces the initial capital investment, and
    allows small scale service providers to leverage
    established brand names for market penetration.
    Leading market players in this market include
    Roche Diagnostic (Switzerland), Life
    Technologies, Corp. (U.S.), QIAGEN (Netherlands),
    Illumina, Inc. (U.S.), and Bio-Rad Laboratories,
    Inc. (U.S.).

  • The Global Genomics Market study is part of the
    Biotechnology subscription title, which also
    includes research in the following markets Next
    Generation Sequencing (NGS) Market Platforms
    (Illumina HiSeq, MiSeq, Life Technologies Ion
    Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq,
    ChIP-Seq), (Pyrosequencing, SBS, SMRT),
    (Diagnostics, Personalized Medicine) Global
    Forecast to 2020, and Proteomics Market (Protein
    Microarray, Mass Spectrometry, NMR Spectroscopy,
    Chromatography, Electrophoresis, Surface Plasmon
    Resonance, X-ray Crystallography) - Instruments,
    Reagents Services - Trends Global Forecasts
    to 2020.All research reports from Markets and
    Markets provide detailed tables and forecasts
    following extensive interviews with market

About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
Contact Us
Mr. RohanMarkets and Markets UNIT no 802, Tower
no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra 411013, India 1-888-600-6441 Email Visit
MarketsandMarkets Blog _at_ http//
-research/healthcare/medical-devices Connect
with us on LinkedIn _at_ http//
Write a Comment
User Comments (0)